Back to search

Article

Transglutaminase 2 exacerbates ovarian cancer survival by inactivating GSK3β

2025-08-13

Abstract excerpt

<title>Abstract</title> <p>Elevated expression of transglutaminase 2 (TGase 2, EC 2.3.2.13, protein-glutamine g-glutamyltransferase, gene name TGM2) is recognized as one of the most upregulated genes during epithelial-mesenchymal transition (EMT) in ovarian cancer. Despite initial complete responses to conventional chemotherapy, ovarian cancer often recurs with metastasis, posing a major clinical challenge. Drug-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
032f839b-7c70-5865-a163-16591cafc19e
DOI
10.21203/rs.3.rs-7297143/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transglutaminase 2 exacerbates ovarian cancer survival by inactivating GSK3βDOI 10.21203/rs.3.rs-7297143/v1
Select a neighboring publication to make it the new centre.